SECENDS - ABT

2025

Q4 4 filings

Nov 21

Temporary Suspension of Trading Under Registrant's Employee Benefit Plans

8-K View →

Nov 20

Abbott Laboratories to Acquire Exact Sciences for $105 per share

$105 per share

8-K View →

Oct 29

Q3 2025 Results

Unable to extract specific revenue and EPS figures from provided XBRL metadata

10-Q View →

Oct 15

Q3 2025 Earnings

Third quarter 2025 results announced

8-K View →

Q3 2 filings

Jul 30

Q2 2025 Results

Unable to extract specific revenue and EPS figures from provided XBRL metadata

10-Q View →

Jul 17

Q2 2025 Earnings

Q2 2025 results announced July 17

8-K View →

Q2 4 filings

May 1

General Counsel Retirement

Hubert L. Allen, EVP General Counsel retiring after transition

8-K View →

Apr 30

Q1 2025 Results

Unable to extract financial data - filing contains only XBRL metadata without actual financial values

10-Q View →

Apr 28

Annual Shareholder Meeting

Board elected, auditors ratified, exec comp approved 89.90%

8-K View →

Apr 16

Q1 2025 Earnings

Q1 2025 results announced

8-K View →

Q1 3 filings

Mar 14

2025 Proxy Statement

Annual meeting: 4/25/25, Record date: 2/26/25, 53rd consecutive dividend increase (+7.3%), TSR: 58th percentile (1yr), 68th percentile (5yr)

DEF 14A View →

Feb 21

Unable to extract - corrupted data

📌 Unable to extract - corrupted data

10-K View →

Jan 22

Q4 2024 Earnings

Q4 and full year 2024 results announced

8-K View →

2024

Q4 3 filings

Nov 15

Change in Control Agreements Extended

Executive agreements extended through Dec 31, 2026

8-K View →

Oct 31

Q3 2024 Results

Financial data not available in provided content

10-Q View →

Oct 16

Q3 2024 Earnings

Third quarter 2024 results announced Oct 16, 2024

8-K View →

Q3 2 filings

Jul 31

Q2 2024 Results

Financial data not extractable from provided content

10-Q View →

Jul 18

Q2 2024 Earnings

Q2 2024 results announced

8-K View →

Q2 4 filings

May 2

Q1 2024 Results

Unable to extract specific revenue and EPS figures from provided XBRL structure data

10-Q View →

May 1

CFO Retirement

Robert E. Funck, Jr. retiring July 1, 2024 after 36 years

8-K View →

Apr 29

Annual Shareholder Meeting

Board re-elected, auditor ratified, exec comp approved 89.10%

8-K View →

Apr 17

Q1 2024 Earnings

First quarter 2024 results announced

8-K View →

Q1 4 filings

Mar 15

2024 Proxy Statement

Say-on-pay: 90%+ support (5 consecutive years), TSR: 225% (7-year cumulative)

DEF 14A View →

Feb 16

FY 2023 Results

Unable to extract specific revenue and EPS figures from provided XBRL metadata

📌 Unable to identify specific milestone from provided XBRL structure data - actual financial values and narrative content not available

10-K View →

Jan 29

Credit Agreement Renewal

$5B revolving credit facility, 5-year term

8-K View →

Jan 24

Q4 2023 Earnings

Q4 and full year 2023 results announced

8-K View →

2023

Q4 2 filings

Nov 1

Q3 2023 Results

Unable to extract revenue and EPS figures from provided XBRL taxonomy data

10-Q View →

Oct 18

Q3 2023 Earnings

Results announced for third quarter 2023

8-K View →

Q3 2 filings

Aug 3

Q2 2023 Results

Unable to extract specific revenue and EPS figures from provided XBRL data

10-Q View →

Jul 20

Q2 2023 Earnings

Q2 2023 results announced July 20

8-K View →